Showing results (181-190 of 216) with videos related to
Sort By:
Pageof 22
Journal of Medicinal Chemistry|December 16, 1997
Tyrosine kinase inhibitors. 13. Structure-activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]pyrido[4,3-d]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptorA M Thompson, D K Murray, W L Elliott, et al.Journal of Medicinal Chemistry|January 1, 1987
Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemiasH D Showalter, J L Johnson, J M Hoftiezer, et al.Digestive Diseases and Sciences|March 15, 2011
Use of enterally delivered angiotensin II type Ia receptor antagonists to reduce the severity of colitisManabu Okawada, Hiroyuki Koga, Scott D Larsen, et al.Nature Chemical Biology|January 31, 2012
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemiaJolanta Grembecka, Shihan He, Aibin Shi, et al.Journal of Medicinal Chemistry|August 24, 2000
Synthesis and structure-activity relationships of 7-substituted 3-(2, 6-dichlorophenyl)-1,6-naphthyridin-2(1H)-ones as selective inhibitors of pp60(c-src)A M Thompson, G W Rewcastle, S L Boushelle, et al.Bioorganic & Medicinal Chemistry|April 25, 2020
Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidines as atypical protein kinase C inhibitors to control retinal vascular permeability and cytokine-induced edemaXuwen Liu, Michael W Wilson, Kun Liu, et al.Molecular Endocrinology (Baltimore, Md.)|July 19, 2013
The identification of novel proteins that interact with the GLP-1 receptor and restrain its activityX Huang, F F Dai, G Gaisano, et al.Journal of Medicinal Chemistry|July 8, 1999
Structure-activity relationships for 5-substituted 1-phenylbenzimidazoles as selective inhibitors of the platelet-derived growth factor receptorB D Palmer, A J Kraker, B G Hartl, et al.Journal of Medicinal Chemistry|August 1, 1988
Benzothiopyranoindazoles, a new class of chromophore modified anthracenedione anticancer agents. Synthesis and activity against murine leukemiasH D Showalter, M M Angelo, E M Berman, et al.Journal of Medicinal Chemistry|February 7, 2001
Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functionsJ B Smaill, G W Rewcastle, J A Loo, et al.Pageof 22